Diferencia entre revisiones de «Template:Typhoid Antibiotics»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
====Oral therapy with Quinolone Susceptibility==== | ====Oral therapy with [[Quinolone]] Susceptibility==== | ||
*Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days | *[[Ciprofloxacin]] 500-750 mg PO q 12 hrs x 14 days | ||
====Parenteral Therapy with Quinolone Susceptibility==== | ====Parenteral Therapy with [[Quinolone]] Susceptibility==== | ||
*Ciprofloxacin 400 mg IV q 12 hrs x 10 days | *[[Ciprofloxacin]] 400 mg IV q 12 hrs x 10 days | ||
====Parenteral Therapy with Quinolone Resistance==== | ====Parenteral Therapy with [[Quinolone]] Resistance==== | ||
:''if nalidixic acid resistant, assume fluoroquinolone resistant'' | :''if nalidixic acid resistant, assume [[fluoroquinolone]] resistant'' | ||
*Ceftriaxone 2mg IV q 24 hrs x 14 days | *[[Ceftriaxone]] 2mg IV q 24 hrs x 14 days | ||
::'''OR''' | ::'''OR''' | ||
*Cefixime 10-15 mg/kg IV q 12 hrs x 8 days | *[[Cefixime]] 10-15 mg/kg IV q 12 hrs x 8 days | ||
====Oral Therapy with Quinolone Resistance==== | |||
*Azithromycin 1 g PO daily x 5 days | ====Oral Therapy with [[Quinolone]] Resistance==== | ||
*[[Azithromycin]] 1 g PO daily x 5 days | |||
Revisión actual - 17:26 12 sep 2014
Oral therapy with Quinolone Susceptibility
- Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days
Parenteral Therapy with Quinolone Susceptibility
- Ciprofloxacin 400 mg IV q 12 hrs x 10 days
Parenteral Therapy with Quinolone Resistance
- if nalidixic acid resistant, assume fluoroquinolone resistant
- Ceftriaxone 2mg IV q 24 hrs x 14 days
- OR
- Cefixime 10-15 mg/kg IV q 12 hrs x 8 days
Oral Therapy with Quinolone Resistance
- Azithromycin 1 g PO daily x 5 days